Self-assembling doxorubicin-prodrug nanoparticles as siRNA drug delivery system for cancer treatment: in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Self-assembling doxorubicin-prodrug nanoparticles as siRNA drug delivery system for cancer treatment: in vitro and in vivo

Published:2014 Issue:35 Volume:2 Page:5910-5924
ISSN:2050-750X
Container-title:J. Mater. Chem. B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Liu Hongmei¹²³⁴⁵,Qiao Chenmeng⁶⁷⁸⁹,Yang Jun¹²³⁴,Weng Jie⁶⁷⁸⁹,Zhang Xin¹²³⁴

Affiliation:

1. National Key Laboratory of Biochemical Engineering

2. Institute of Process Engineering

3. Chinese Academy of Sciences

4. Beijing, PR China

5. University of Chinese Academy of Sciences

6. Key Laboratory of Advanced Technologies of Materials

7. School of Materials Science and Engineering

8. Southwest Jiaotong University

9. Chengdu, PR China

Abstract

The DOX-prodrug NPs can complex siRNA in pH 3 citrate buffer and have slight negative charges on the surface of NPs in pH 7.4 PBS.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2014/TB/C4TB00814F

Reference49 articles.

1. Global cancer statistics

2. Advanced Materials for Co-Delivery of Drugs and Genes in Cancer Therapy

3. Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment

4. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells

5. Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision arrows: Navigating breast cancer with nanotechnology siRNA;International Journal of Pharmaceutics;2024-09

2. Dual Reduction-Sensitive Nanomicelles for Antitumor Drug Delivery with Low Toxicity to Normal Cells;ACS Applied Nano Materials;2024-06-28

3. Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapy;International Journal of Biological Sciences;2023

4. Construction of functionalized ruthenium-modified selenium coated with pH-responsive silk fibroin nanomaterials enhanced anticancer efficacy in hepatocellular cancer;Process Biochemistry;2022-11

5. Precise engineering of cholesterol-loaded chitosan micelles as a promising nanocarrier system for co-delivery drug-siRNA for the treatment of gastric cancer therapy;Process Biochemistry;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3